Vesper Bio ApS: Financial statements 2020
CVR: 32879861
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Vesper Bio ApS (CVR 32879861) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -6,780,427 and a net result of DKK -7,955,052 compared with DKK -2,769,107 the year before. Equity in the 2020 report amounted to DKK -6,831,101. The company had 1 employee in the financial year.
- Gross Profit
- DKK -6,780,427
- Profit/Loss
- DKK -7,955,052
- Equity
- DKK -6,831,101
- Total Assets
- DKK 5,883,671
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -6.8 mio. | -8 mio. | -6.8 mio. | 1 |
| 2019 | - | - | -2.8 mio. | 1.1 mio. | 1 |
| 2018 | - | - | -4 mio. | 3.9 mio. | 1 |
| 2017 | - | - | -2.7 mio. | 7.9 mio. | 0 |
| 2016 | - | - | -4 mio. | 3.1 mio. | - |
Official annual report
How creditworthy is Vesper Bio ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Vesper Bio ApS has published its annual report for 2019. The net result was DKK -2,769,107.
About Vesper Bio ApS
Vesper Bio ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2010. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named INSUSENSE ApS. The management consists of Jacob Falck Hansen. The company is owned by 75PMK Holding ApS and LUNDBECKFONDEN. The company has 3 employees (2018). In 2025, the company reported a gross profit of DKK -36,446,130 and a net result of DKK -48,200,991 compared with DKK -66,506,349 the year before. Equity in the 2025 report amounted to DKK -227,433,239.